Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Virtual Colonography Recommended for Colon Cancer Screening

By HospiMedica International staff writers
Posted on 18 Mar 2011
In the United States, in spite of the absence of healthcare (US Medicare) coverage, hospital utilization of computed tomographic colonography (CTC) imaging, typically referred to as virtual colonoscopy, is on the rise, according to new research.

The study's findings were published in the March 2011 issue of the Journal of the American College of Radiology. More...
Colorectal cancer is the second leading cause of cancer deaths in the United States. CTC, a minimally invasive option to optical colonoscopy for colorectal cancer screening, utilizes virtual reality technology to generate a three-dimensional (3D) visualization that permits a comprehensive assessment of the entire colon and rectum.

Data on the provision of colorectal cancer screening services by nonfederal, general hospitals were analyzed using the 2005 to 2008 American Hospital Association annual surveys. Moreover, in 2009, exploratory interviews were conducted with representatives from radiology departments at nine hospitals--six that provided CTC and three that did not. Researchers discovered that in 2008, 17% of hospitals offered CTC, up from 13% in 2005. Sixty-nine percent of hospitals that offered CTC in 2008 also offered optical colonoscopy services. Factors motivating the adoption of CTC included a desire to provide an alternative screening option for frail, elderly patients and patients with failed optical colonoscopy; long waits for optical colonoscopy; and promising evidence on CTC published in peer-reviewed literature. Lack of reimbursement was a commonly cited barrier.

"Our study is unique in that we show expansion even in the absence of Medicare reimbursement for CTC for general screening. CTC's relatively easy implementation coupled with patient acceptance makes CTC a tool that holds promise for the future of colorectal cancer prevention,” said Megan McHugh, PhD, director of research at the Health Research and Education Trust (HRET; Washington DC, USA), and lead author of the study.

CTC is validated in clinical trials to be as effective as standard colonoscopy at detecting clinically significant lesions in average risk patients and is endorsed by the American Cancer Society as a recommended colon cancer-screening test. However, Medicare does not cover seniors for CTC. As policymakers and others consider ways to increase colorectal cancer screening, it is important to understand US hospitals' readiness to offer CTC and the factors that facilitate or impede adoption, according to the investigators.

Related Links:

Health Research and Education Trust



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Hypodermic Syringe
SurTract™ Safety Syringe
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.